Literature DB >> 9177394

Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain.

C Mantzoros1, J S Flier, M D Lesem, T D Brewerton, D C Jimerson.   

Abstract

Studies in rodents have shown that leptin acts in the central nervous system to modulate food intake and energy metabolism. To evaluate the possible role of leptin in the weight loss of anorexia nervosa, this study compared cerebrospinal fluid (CSF) and plasma leptin concentrations in anorexic patients and controls. Subjects included 11 female patients with anorexia nervosa studied at low weight and after treatment, and 15 healthy female controls. Concentrations of leptin in blood and CSF were measured by RIA. Patients with anorexia nervosa, compared to controls, had decreased concentrations of leptin in CSF (98 +/- 26 vs. 160 +/- 58 pg/mL; P < 0.0005) and plasma (1.75 +/- 0.46 vs. 7.01 +/- 3.92 ng/mL; P < 0.005). The CSF to plasma leptin ratio, however, was higher for patients (0.060 +/- 0.023) than for controls (0.025 +/- 0.007; P < 0.0001). At posttreatment testing, although patients had not yet reached normal body weight, CSF and plasma leptin concentrations had increased to normal levels. These results demonstrate the dynamic changes in plasma and CSF leptin during positive energy balance in anorexia nervosa. The results further suggest that normalization of CSF leptin levels before full weight restoration during treatment of anorexic patients could contribute to resistance to weight gain and/or incomplete weight recovery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177394     DOI: 10.1210/jcem.82.6.4006

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Gonadotropin response to clomiphene and plasma leptin levels in weight recovered but amenorrhoeic patients with anorexia nervosa.

Authors:  M Djurovic; S Pekic; M Petakov; S Damjanovic; M Doknic; C Dieguez; F F Casanueva; V Popovic
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 2.  Dietary components in the development of leptin resistance.

Authors:  Joseph R Vasselli; Philip J Scarpace; Ruth B S Harris; William A Banks
Journal:  Adv Nutr       Date:  2013-03-01       Impact factor: 8.701

3.  Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalities.

Authors:  F Jacoangeli; S Masala; F Staar Mezzasalma; R Fiori; A Martinetti; C Ficoneri; B Novi; S Pierangeli; G Marchetti; G Simonetti; M R Bollea
Journal:  Eat Weight Disord       Date:  2006-03       Impact factor: 4.652

4.  Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women.

Authors:  J Licinio; A B Negrão; C Mantzoros; V Kaklamani; M L Wong; P B Bongiorno; A Mulla; L Cearnal; J D Veldhuis; J S Flier; S M McCann; P W Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Leptin and hunger levels in young healthy adults after one night of sleep loss.

Authors:  Slobodanka Pejovic; Alexandros N Vgontzas; Maria Basta; Marina Tsaoussoglou; Emmanuel Zoumakis; Angeliki Vgontzas; Edward O Bixler; George P Chrousos
Journal:  J Sleep Res       Date:  2010-12       Impact factor: 3.981

Review 6.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

Review 7.  Narrative review: the role of leptin in human physiology: emerging clinical applications.

Authors:  Theodore Kelesidis; Iosif Kelesidis; Sharon Chou; Christos S Mantzoros
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

8.  Inhibition of leptin regulation of parasympathetic signaling as a cause of extreme body weight-associated asthma.

Authors:  Emilio Arteaga-Solis; Tiffany Zee; Charles W Emala; Charles Vinson; Jürgen Wess; Gerard Karsenty
Journal:  Cell Metab       Date:  2013-01-08       Impact factor: 27.287

9.  Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity.

Authors:  Eran Elinav; Leonora Niv-Spector; Meirav Katz; Tulin O Price; Mohammed Ali; Michal Yacobovitz; Gili Solomon; Shay Reicher; Jessica L Lynch; Zamir Halpern; William A Banks; Arieh Gertler
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

10.  The impact of hyperactivity and leptin on recovery from anorexia nervosa.

Authors:  A A van Elburg; M J H Kas; J J G Hillebrand; R J C Eijkemans; H van Engeland
Journal:  J Neural Transm (Vienna)       Date:  2007-05-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.